
Profitability, historical returns, and peer comparisons.
According to Glorywin Entertainment Group, Inc.’s latest financial reports and current stock price. The company's current ROE is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical ROE of Glorywin Entertainment Group, Inc. over the last ten years is 209.58%. The current 0% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), GWIN's ROE was at its highest in in the March 2016 quarter at 19.10%. The ROE was at its lowest in in the September 2012 quarter at -100.75%.
Average
209.58%
Median
0%
Minimum
0%
Maximum
2.08%
Discovering the peaks and valleys of Glorywin Entertainment Group, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 2.08%
Minimum Annual Increase = 0%
Minimum Annual ROE = 0%
| Year | ROE | Change |
|---|---|---|
| 2026 | 0% | 0% |
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | -100.00% |
| 2018 | 12.88% | -99.38% |
| 2017 | 2.08% | -76.39% |
The current ROE of Glorywin Entertainment Group, Inc. (GWIN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
209.58%
Glorywin Entertainment Group, Inc.’s ROE is greater than CollPlant Biotechnologies Ltd. (-215.58%), greater than BICO Group AB (publ) (-49.84%), greater than Axe Compute Inc. (-2273.26%), greater than Champions Oncology, Inc. (-27.88%), less than BlossomHill Therapeutics, Inc. (127.76%), greater than Black Diamond Therapeutics, Inc. (-38.80%), greater than Disc Medicine, Inc. (-37.17%), greater than Vor Biopharma Inc. (-830.38%), greater than Greenwich LifeSciences, Inc. (-793.76%), greater than Century Therapeutics, Inc. (-52.76%),
| Company | ROE | Market cap |
|---|---|---|
| -215.58% | $7.66M | |
| -49.84% | $173.61M | |
| -2273.26% | $90.97M | |
| -27.88% | $66.95M | |
| 127.76% | $365.70M | |
| -38.80% | $104.58M | |
| -37.17% | $3.03B | |
| -830.38% | $1.06B | |
| -793.76% | $248.10M | |
| -52.76% | $267.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glorywin Entertainment Group, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Glorywin Entertainment Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Glorywin Entertainment Group, Inc.'s ROE?
How is the ROE calculated for Glorywin Entertainment Group, Inc. (GWIN)?
What is the highest ROE for Glorywin Entertainment Group, Inc. (GWIN)?
What is the 3-year average ROE for Glorywin Entertainment Group, Inc. (GWIN)?
What is the 5-year average ROE for Glorywin Entertainment Group, Inc. (GWIN)?
How does the current ROE for Glorywin Entertainment Group, Inc. (GWIN) compare to its historical average?